KIRKLAND, Wash., Feb. 12, 2019 (GLOBE NEWSWIRE) -- GrowLife, Inc. (OTCQB:PHOT), one of the nation's most recognized indoor cultivation product and service providers, today announced that the company will be attending the Seed to Sale show in Boston, Massachusetts, on Feb. 12 and Feb. 13, 2019, as an exhibitor. GrowLife will showcase its EZ-CLONE Pro commercial propagation solution, manufactured by recently majority acquired asset EZ-CLONE Enterprises, Inc. (EZ-CLONE), at booth #635. EZ-CLONE is a renowned commercial cannabis cultivation equipment supplier that GrowLife acquired a majority share of in October 2018.
The Seed to Sale Show is known as the cannabis industry’s most influential trade association event. A leader in the industry, the Seed to Sale Show will allow GrowLife executives to meet with prominent people and companies in the cannabis space. Known as the market’s only true B2B cannabis summit, the show acts as an opportunity to network with leaders in the industry as well as a platform for learning and demonstrating the latest advances in science and technology.
“The opportunity to participate in this show could not have come at a better time with the rapid expansion the Massachusetts market is experiencing, coupled with the recent passing of the Farm Bill which legalized hemp nationwide, with most hemp being grown on the East Coast,” said GrowLife Hydroponics Division President Joe Barnes. “Boston has become a hotspot for industry growth along the East Coast and with more than 3,000 attendees eager to learn more about the latest innovations in the industry, we are looking forward to educating a focused group of people on how GrowLife and EZ-CLONE stand out in the cannabis industry in terms of cultivation solutions. From forming new business prospects to strengthening client relationships, the Seed to Sale Show is an excellent opportunity that we are thrilled to be part of, especially as we will get to showcase the EZ-Clone Pro commercial model which is in extremely high demand throughout the industry.”
Recently acquired asset EZ-CLONE is a manufacturer of multiple award-winning products that are specifically designed for the commercial cloning and propagation stage of indoor plant cultivation. Products are utilized for cannabis, food, and other hydroponic farming. The acquisition aligns with GrowLife’s strategic vision of servicing the burgeoning cannabis cultivation market.
Interested attendees can find more information and register for attendance here. To see GrowLife and EZ-CLONE at the Seed to Sale Show, visit booth #635.
For more information about GrowLife, please visit the company's website. Products can be purchased at ShopGrowLife.com. Additional commentary on the company and the industry as a whole can be found on the CEO's blog.
About GrowLife, Inc.
GrowLife, Inc. (PHOT) aims to become the nation’s largest cultivation service provider for cultivating organics, herbs and greens and plant-based medicines. Our mission is to help make our customers successful. Through a network of local representatives covering the United States and Canada, regional centers and its e-Commerce team, GrowLife provides essential goods and services including media, industry-leading hydroponics and soil, plant nutrients, and thousands more products to specialty grow operations. GrowLife is headquartered in Kirkland, Washington and was founded in 2012.
About EZ-CLONE Enterprises, Inc.
This U.S. company sells solutions for hydroponic and aeroponic systems around the world. EZ-CLONE provides a lifetime warranty on the quality of their products. EZ-CLONE won awards in the industry for “Best aeroponic machine for vegetative propagation” and “Best New Product for Gardening.”
Investor Relations Contact:
FORWARD LOOKING STATEMENT:
This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of GrowLife, Inc., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words may, would, will, expect, estimate, can, believe, potential and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond GrowLife, Inc.’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors.